BLAISE LUCILE 4
4 · RESMED INC · Filed Nov 16, 2022
Insider Transaction Report
Form 4
RESMED INCRMD
BLAISE LUCILE
President, Sleep & RC Business
Transactions
- Sale
ResMed Common Stock
2022-11-15$225.18/sh−169$38,055→ 7,335 total - Exercise/Conversion
ResMed Common Stock
2022-11-15$225.18/sh+516$116,193→ 7,504 total
Footnotes (2)
- [F1]The transaction was conducted under a Rule 10b5-1 plan.
- [F2]Includes 72.515 shares of ResMed stock purchased on October 31, 2022, through the ResMed Employee Stock Purchase Plan.